HK2 and Alzheimer disease: Additionally, in an AD mouse model, pharmacological inhibition of hexokinase 2 (HK2), a key glycolytic enzyme, increased LPL expression, which in turn regulated lipid metabolism and was associated with reduced amyloid load and improved cognitive function [75].